FKBP8 inhibits virus-induced RLR-VISA signaling

Shan-Shan Xu1, Liang-Guo Xu1, Cailei Yuan2

  • 1Key Laboratory of Functional Small Organic Molecules, Ministry of Education and College of Life Science, Jiangxi Normal University, Nanchang, China.

Journal of Medical Virology
|September 30, 2018
PubMed

Insights

FK506 binding protein 8 (FKBP8) negatively regulates innate immunity antiviral signaling by targeting the VISA pathway. FKBP8 inhibits key signaling complex formation and promotes protein degradation, enhancing virus replication.

Area of Science:

  • Immunology
  • Molecular Biology
  • Virology

Background:

  • The mitochondrial antiviral signaling protein (VISA) is crucial for innate immune responses against viral infections.
  • Understanding regulators of VISA signaling is vital for developing antiviral strategies.

Purpose of the Study:

  • To identify novel interacting partners of VISA.
  • To elucidate the role of FK506 binding protein 8 (FKBP8) in antiviral innate immunity.

Main Methods:

  • Yeast two-hybrid screening to identify interacting proteins.
  • Coimmunoprecipitation assays to confirm interactions in mammalian cells.
  • Reporter gene assays and RNA interference to assess functional effects.
  • Western blotting to analyze protein degradation and ubiquitination.

Main Results:

  • FKBP8 was identified as an interacting protein of VISA, RIG-I, and IRF3.
  • Overexpression of FKBP8 attenuated virus-induced IFN-β, NF-κB, and ISRE activation.
  • FKBP8 inhibited TBK1-IRF3 and VISA-TRAF3 complex formation and promoted RIG-I, TBK1, and TRAF3 degradation.
  • FKBP8 knockdown reversed these effects, enhancing antiviral signaling.

Conclusions:

  • FKBP8 acts as a negative regulator of the RLR-VISA signaling pathway.
  • FKBP8 modulates innate immunity by inhibiting signaling complex formation and promoting protein degradation.
  • This study reveals a novel role for FKBP8 in antiviral defense.

Related Concept Videos

Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.2K
What are Viruses?00:50

What are Viruses?

Overview
128.2K
Bacterial Signaling01:30

Bacterial Signaling

Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
40.8K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.5K
What is Cell Signaling?02:03

What is Cell Signaling?

Despite the protective membrane that separates a cell from the environment, cells need the ability to detect and respond to environmental changes. Additionally, cells often need to communicate with one another. Unicellular and multicellular organisms use a variety of cell signaling mechanisms to communicate to respond to the environment.
130.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K